Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
1.570
+0.210 (15.44%)
At close: Dec 20, 2024, 4:00 PM
1.560
-0.010 (-0.64%)
After-hours: Dec 20, 2024, 7:54 PM EST
Biodesix Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$3.08
Upside
+96.18%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Buy Initiates $3 | Buy | Initiates | $3 | +91.08% | Sep 16, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +91.08% | Jul 26, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates $2.8 | Strong Buy | Initiates | $2.8 | +78.34% | May 13, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +122.93% | Mar 4, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +122.93% | Dec 7, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +218.47% | May 12, 2022 |
| Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 20, 2022 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $21 → $11 | Buy → Hold | Downgrades | $21 → $11 | +600.64% | Nov 17, 2021 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $25 → $23 | Buy | Maintains | $25 → $23 | +1,364.97% | May 12, 2021 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $20 → $25 | Buy | Maintains | $20 → $25 | +1,492.36% | Mar 18, 2021 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $27 → $31 | Strong Buy | Maintains | $27 → $31 | +1,874.52% | Feb 2, 2021 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 23, 2020 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $20 | Buy | Initiates | $20 | +1,173.89% | Nov 23, 2020 |